Exploring the Physician Perspective & Approaches to Mitigate ADC Toxicity & Improve Clinical Safety

• Contextualizing ADC clinical class effect toxicities to understand barriers to progression to standard of care and early-stage therapies
• Explaining the physician’s perspective and patient attitudes to ADC treatments given anti-tumor efficacy and associated toxicity profiles
• Breaking down clinical toxicity mitigation strategies: What are the top learnings to pass back to ADC developers?

Speakers:

Aditya Bardia

Program Director, Breast Medical Oncology & Assistant Chief, Translational Research, Hematology/Oncology Division

UCLA Health